XENE

XENE

USD

Xenon Pharmaceuticals Inc. Common Shares

$39.090-0.650 (-1.636%)

Echtzeitkurs

Healthcare
Biotechnologie
Kanada

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$39.740

Hoch

$40.450

Tief

$37.625

Volumen

0.18M

Unternehmensfundamentaldaten

Marktkapitalisierung

3.0B

Branche

Biotechnologie

Land

Canada

Handelsstatistiken

Durchschnittliches Volumen

0.79M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $26.74Aktuell $39.090Hoch $46

Ähnliche Nachrichten

Analyst Upgrades

RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.

Mehr anzeigen
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
Analyst Upgrades

Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44

Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.

Mehr anzeigen
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Analyst Upgrades

Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.

Mehr anzeigen
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
GlobeNewswire

Xenon to Report Q3 2025 Financial Results on November 3, 2025

VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and

Mehr anzeigen
Xenon to Report Q3 2025 Financial Results on November 3, 2025

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.